Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4462691000168114 | Gefitinib (Cipla) (gefitinib 250 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4462701000168114 | Gefitinib (Cipla) 250 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gefitinib (Cipla) 250 mg tablet | Is a | Gefitinib (Cipla) | true | Inferred relationship | Some | ||
| Gefitinib (Cipla) 250 mg tablet | Is a | gefitinib 250 mg tablet | true | Inferred relationship | Some | ||
| Gefitinib (Cipla) 250 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Gefitinib (Cipla) 250 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Gefitinib (Cipla) 250 mg tablet | has Australian BoSS | gefitinib | true | Inferred relationship | Some | 459948673 | |
| Gefitinib (Cipla) 250 mg tablet | has intended active ingredient | gefitinib | true | Inferred relationship | Some | 459948673 | |
| Gefitinib (Cipla) 250 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 565140120 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gefitinib (Cipla) 250 mg tablet, 30, blister pack | has TPUU | True | Gefitinib (Cipla) 250 mg tablet | Inferred relationship | Some | 488382730 |
| Gefitinib (Cipla) 250 mg tablet, 30 | has TPUU | True | Gefitinib (Cipla) 250 mg tablet | Inferred relationship | Some | 1189977681 |
Reference Sets
Trade product unit of use reference set
FHIR